Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 9.02
-0.04 (-0.44%)
Last updated: May 28, 2026, 1:15 PM CET
Svas Biosana Revenue
In the year 2025, Svas Biosana had annual revenue of 141.56M EUR with 15.76% growth. Svas Biosana had revenue of 69.85M in the half year ending December 31, 2025, with 7.88% growth.
Revenue
141.56M
Revenue Growth
+15.76%
P/S Ratio
0.33
Revenue / Employee
406.77K
Employees
348
Market Cap
47.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 141.56M | 19.27M | 15.76% |
| Dec 31, 2024 | 122.29M | 656.90K | 0.54% |
| Dec 31, 2023 | 121.63M | 22.12M | 22.22% |
| Dec 31, 2022 | 99.51M | 17.52M | 21.37% |
| Dec 31, 2021 | 81.99M | 4.72M | 6.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| EL.En. | 594.84M |
| GPI S.p.A. | 546.18M |
| Talea Group | 132.17M |
| Farmacosmo | 59.23M |
| EuKedos | 52.91M |